ANURAS vs EPIGRAL: Stock Comparison

Anupam Rasayan India Limited vs Epigral Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Anupam Rasayan India Limited is the larger company by market capitalisation. Anupam Rasayan India Limited shows faster revenue growth, while Epigral Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Anupam Rasayan India Limited and Epigral Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ANURAS is more favourable on 3 of 13 scored metrics and EPIGRAL on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ANURAS is the larger company
₹14,231 Cr vs ₹5,036 Cr
P/E Ratio
EPIGRAL has a lower P/E
15.04x vs 82.46x
P/B Ratio
EPIGRAL has a lower P/B
2.25x vs 4.21x
EPS
EPIGRAL has higher earnings per share
₹75.27 vs ₹15.45
Dividend Yield
EPIGRAL has a higher dividend yield
0.43% vs 0.12%
Revenue Growth (TTM YoY)
ANURAS has faster revenue growth
27.5% vs 17.3%
EPS Growth (TTM YoY)
EPIGRAL has faster EPS growth
-6.8% vs -7.6%
Qtr Sales Growth
ANURAS has stronger quarterly sales growth
27.1% vs 17.3%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricANURASEPIGRAL
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricANURASEPIGRAL
Live Price₹1,249.6₹1,162.7
Day Change0.85%0.93%
Volume2.82 L3.02 L
52-Week High₹1,415₹2,114
52-Week Low₹1,045.2₹807
Distance from 52W High-11.69%-45%

Valuation

MetricANURASEPIGRAL
Market Cap₹14,231 Cr₹5,036 Cr
P/E Ratio82.46x15.04x
P/B Ratio4.21x2.25x
EPS₹15.45₹75.27
Book Value₹293.12₹514.92
Dividend Yield0.12%0.43%

Growth

MetricANURASEPIGRAL
Revenue Growth (TTM YoY)27.5%17.3%
EPS Growth (TTM YoY)-7.6%-6.8%
Qtr Sales Growth27.1%17.3%
Qtr Profit Growth-4.31%-6.84%

Profitability & Leverage

MetricANURASEPIGRAL
ROE5.5%16%
ROCE7.36%15.5%
Net Margin8.41%13.14%
Operating Margin22.2%22.4%
Debt to Equity0.56x0.26x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricANURASEPIGRAL
Promoter Holding27.27%68.83%
FII Holding7.71% 0.8 pp1.03% 0.51 pp
DII Holding0.38% 0.03 pp5.56% 0.66 pp
Public Holding32.83% 0.84 pp24.55% 0.15 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Anupam Rasayan India Limited and Epigral Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.